These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16580497)

  • 1. A modified inflammatory bowel disease questionnaire and the Vaizey Incontinence questionnaire are more sensitive measures of acute gastrointestinal toxicity during pelvic radiotherapy than RTOG grading.
    Khalid U; McGough C; Hackett C; Blake P; Harrington KJ; Khoo VS; Tait D; Norman AR; Andreyev HJ
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1432-41. PubMed ID: 16580497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A modified Inflammatory Bowel Disease questionnaire and the Vaizey Incontinence questionnaire are simple ways to identify patients with significant gastrointestinal symptoms after pelvic radiotherapy.
    Olopade FA; Norman A; Blake P; Dearnaley DP; Harrington KJ; Khoo V; Tait D; Hackett C; Andreyev HJ
    Br J Cancer; 2005 May; 92(9):1663-70. PubMed ID: 15856043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can biological markers act as non-invasive, sensitive indicators of radiation-induced effects in the gastrointestinal mucosa?
    Wedlake L; McGough C; Hackett C; Thomas K; Blake P; Harrington K; Tait D; Khoo V; Dearnaley D; Andreyev HJ
    Aliment Pharmacol Ther; 2008 May; 27(10):980-7. PubMed ID: 18315578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small bowel bacterial overgrowth and lactose intolerance during radical pelvic radiotherapy: An observational study.
    Wedlake L; Thomas K; McGough C; Andreyev HJ
    Eur J Cancer; 2008 Oct; 44(15):2212-7. PubMed ID: 18760593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal symptoms after pelvic radiotherapy: role for the gastroenterologist?
    Andreyev HJ; Vlavianos P; Blake P; Dearnaley D; Norman AR; Tait D
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1464-71. PubMed ID: 15927411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting late effects of pelvic radiotherapy: is there a better approach?
    Wedlake LJ; Thomas K; Lalji A; Blake P; Khoo VS; Tait D; Andreyev HJ
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1163-70. PubMed ID: 20231077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing measures of acute bowel toxicity in patients with prostate cancer treated with external beam radiation therapy.
    Muanza TM; Albert PS; Smith S; Godette D; Crouse NS; Cooley-Zgela T; Sciuto L; Camphausen K; Coleman CN; Ménard C
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1316-21. PubMed ID: 16029787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structured gastroenterological intervention and improved outcome for patients with chronic gastrointestinal symptoms following pelvic radiotherapy.
    Henson CC; Davidson SE; Ang Y; Babbs C; Crampton J; Kelly M; Lal S; Limdi JK; Whatley G; Swindell R; Makin W; McLaughlin J
    Support Care Cancer; 2013 Aug; 21(8):2255-65. PubMed ID: 23512314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial: normal diet vs. partial replacement with oral E028 formula for the prevention of gastrointestinal toxicity in cancer patients undergoing pelvic radiotherapy.
    McGough C; Wedlake L; Baldwin C; Hackett C; Norman AR; Blake P; Harrington K; Tait D; Khoo V; Frost G; Andreyev HJ
    Aliment Pharmacol Ther; 2008 Jun; 27(11):1132-9. PubMed ID: 18315590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy.
    Langendijk JA; Doornaert P; Verdonck-de Leeuw IM; Leemans CR; Aaronson NK; Slotman BJ
    J Clin Oncol; 2008 Aug; 26(22):3770-6. PubMed ID: 18669465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selecting an outcome measure for evaluating treatment in fecal incontinence.
    Deutekom M; Terra MP; Dobben AC; Dijkgraaf MG; Felt-Bersma RJ; Stoker J; Bossuyt PM
    Dis Colon Rectum; 2005 Dec; 48(12):2294-301. PubMed ID: 16400514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of chronic radiation enteritis following radiotherapy for cervical or endometrial cancer and its impact on quality of life.
    Abayomi J; Kirwan J; Hackett A
    Eur J Oncol Nurs; 2009 Sep; 13(4):262-7. PubMed ID: 19640788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inconclusive psychometric properties of the Vaizey score in fecally incontinent patients: a prospective cohort study.
    Bols EM; Hendriks EJ; Deutekom M; Berghmans BC; Baeten CG; de Bie RA
    Neurourol Urodyn; 2010 Mar; 29(3):370-7. PubMed ID: 19634170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can differences in bowel function after surgery for rectal cancer be identified by the European Organization for Research and Treatment of Cancer quality of life instrument?
    Neuman HB; Schrag D; Cabral C; Weiser MR; Paty PB; Guillem JG; Minsky BD; Wong WD; Temple LK
    Ann Surg Oncol; 2007 May; 14(5):1727-34. PubMed ID: 17265117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of lateral internal sphincterotomy for chronic anal fissure with particular reference to quality of life.
    Menteş BB; Tezcaner T; Yilmaz U; Leventoğlu S; Oguz M
    Dis Colon Rectum; 2006 Jul; 49(7):1045-51. PubMed ID: 16598404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of the prevalence and severity of fatigue in patients with prostate cancer undergoing radical external beam radiotherapy and neoadjuvant hormone therapy.
    Truong PT; Berthelet E; Lee JC; Petersen R; Lim JT; Gaul CA; Pai H; Blood P; Ludgate CM
    Can J Urol; 2006 Jun; 13(3):3139-46. PubMed ID: 16813705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial.
    Nout RA; Putter H; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Mens JW; Slot A; Stenfert Kroese MC; van Bunningen BN; Smit VT; Nijman HW; van den Tol PP; Creutzberg CL
    J Clin Oncol; 2009 Jul; 27(21):3547-56. PubMed ID: 19546404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: preliminary results of a multicenter prospective study.
    Fiorino C; Fellin G; Rancati T; Vavassori V; Bianchi C; Borca VC; Girelli G; Mapelli M; Menegotti L; Nava S; Valdagni R
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1130-7. PubMed ID: 17881142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a set of nomograms to predict acute lower gastrointestinal toxicity for prostate cancer 3D-CRT.
    Valdagni R; Rancati T; Fiorino C; Fellin G; Magli A; Baccolini M; Bianchi C; Cagna E; Greco C; Mauro FA; Monti AF; Munoz F; Stasi M; Franzone P; Vavassori V
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1065-73. PubMed ID: 18234449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrical stimulation and pelvic floor muscle training with biofeedback in patients with fecal incontinence: a cohort study of 281 patients.
    Terra MP; Dobben AC; Berghmans B; Deutekom M; Baeten CG; Janssen LW; Boeckxstaens GE; Engel AF; Felt-Bersma RJ; Slors JF; Gerhards MF; Bijnen AB; Everhardt E; Schouten WR; Bossuyt PM; Stoker J
    Dis Colon Rectum; 2006 Aug; 49(8):1149-59. PubMed ID: 16773492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.